Cochrane Abstracts
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Aspirin or Heparin or Both for Improving Pregnancy Outcomes in Women With Persistent Antiphospholipid Antibodies and Recurrent Pregnancy Loss." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433348/all/Aspirin_or_heparin_or_both_for_improving_pregnancy_outcomes_in_women_with_persistent_antiphospholipid_antibodies_and_recurrent_pregnancy_loss_New. Accessed 29 September 2023.
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433348/all/Aspirin_or_heparin_or_both_for_improving_pregnancy_outcomes_in_women_with_persistent_antiphospholipid_antibodies_and_recurrent_pregnancy_loss_New. Accessed September 29, 2023.
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/433348/all/Aspirin_or_heparin_or_both_for_improving_pregnancy_outcomes_in_women_with_persistent_antiphospholipid_antibodies_and_recurrent_pregnancy_loss_New
Aspirin or Heparin or Both for Improving Pregnancy Outcomes in Women With Persistent Antiphospholipid Antibodies and Recurrent Pregnancy Loss [Internet]. In: Cochrane Abstracts. [cited 2023 September 29]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433348/all/Aspirin_or_heparin_or_both_for_improving_pregnancy_outcomes_in_women_with_persistent_antiphospholipid_antibodies_and_recurrent_pregnancy_loss_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss
ID - 433348
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433348/all/Aspirin_or_heparin_or_both_for_improving_pregnancy_outcomes_in_women_with_persistent_antiphospholipid_antibodies_and_recurrent_pregnancy_loss_New
DB - Evidence Central
DP - Unbound Medicine
ER -
